Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
66.58
+0.71 (1.08%)
At close: May 12, 2025, 4:00 PM
66.70
+0.12 (0.18%)
Pre-market: May 13, 2025, 7:53 AM EDT
Halozyme Therapeutics (HALO) Operating Expense Breakdown
History
| Date | Cost of Sales | Selling, General, and Administrative | Amortization | Research and Development |
|---|---|---|---|---|
| Mar 31, 2025 | 179.49M | 161.56M | 71.05M | 74.74M |
| Dec 31, 2024 | 159.42M | 154.34M | 71.05M | 79.05M |
| Sep 30, 2024 | 169.66M | 149.69M | 71.05M | 79.94M |
| Jun 30, 2024 | 175.06M | 143.72M | 73.63M | 78.81M |
| Mar 31, 2024 | 185.52M | 146.96M | 73.70M | 77.50M |
| Dec 31, 2023 | 192.36M | 149.18M | 73.77M | 76.36M |
| Sep 30, 2023 | 182.18M | 149.32M | 60.56M | 77.59M |
| Jun 30, 2023 | 174.68M | 148.52M | 67.42M | 76.98M |
| Mar 31, 2023 | 158.55M | 167.05M | 60.98M | 72.73M |
| Dec 31, 2022 | 139.30M | 143.53M | 43.15M | 66.61M |
| Sep 30, 2022 | 118.77M | 119.55M | 38.60M | 54.15M |
| Jun 30, 2022 | 90.04M | 98.25M | 11.40M | 45.93M |
| Mar 31, 2022 | 79.12M | 53.10M | - | 38.52M |
| Dec 31, 2021 | 81.41M | 50.32M | - | 35.67M |
| Sep 30, 2021 | 86.10M | 46.98M | - | 32.94M |
| Jun 30, 2021 | 73.08M | 45.51M | - | 32.21M |
| Mar 31, 2021 | 55.80M | 44.16M | - | 33.09M |
| Dec 31, 2020 | 43.37M | 45.74M | - | 34.24M |
| Sep 30, 2020 | 33.78M | 59.24M | - | 71.97M |
| Jun 30, 2020 | 50.55M | 65.52M | - | 94.68M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.